1. Dipartimento di Biomedicina e Prevenzione, Università degli Studi di Roma "Tor Vergata", Roma, Italia.
2. ProxAgen OOD, Sofia, Bulgaria.
3. WHO Collaborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italia.
4. Public Health Consulting Group SAGL, Lugano, Switzerland.
5. Clínica en Tuberculosis y Enfermedades Pleurales, Instituto Nacional de Enfermedades Respiratorias - INER - Ciudad de México, México.
6. Instituto de Doenças do Tórax, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro (RJ) Brasil.
7. Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
8. Department of Paediatric Infectious Diseases and Immunology, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
9. Great Ormond Street Hospital Institute of Child Health, University College London, London, United Kingdom.
10. SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
11. National Institute of Hygiene, Rabat, Morocco.
12. Unità di Ricerca Translazionale, Dipartimento di Epidemiologia e Ricerca Preclinica, Istituto Nazionale per le Mallatie Infettive - INMI - Lazzaro Spallanzani, Roma, Italia.
13. Homerthon University Hospital, London, United Kingdom.
A. Publicação póstuma.
Recebido: 29 junho 2017.
Aprovado: 3 setembro 2017.
Estudo realizado pelo TB Diagnostic Survey Working Group.

Endereço para correspondência:
Giovanni Battista Migliori. WHO Collaborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italia.
Tel.: 39 0331 829404. Fax: 39 0331 829402. E-mail: giovannibattista.migliori@fsm.it
Apoio financeiro: Nenhum.